SEC 13F Intelligence

Surevest, LLC / BMY

Surevest, LLC’s Bristol-Myers Squibb Co Position

Does Surevest, LLC own Bristol-Myers Squibb Co (BMY)? Yes52.8K shares worth $4M (+1.02% of its 13F portfolio) as of Q3 2022, down from 53.1K shares the prior filed quarter.

Position Value
$4M
Q3 2022
Shares
52.8K
% of Portfolio
+1.02%
Quarters Held
16
currently held

Position History BMY

Reported value by quarter
Q4 ’18: $272,000Q4 ’18Q1 ’19: $315,000Q2 ’19: $663,000Q2 ’19Q3 ’19: $980,000Q4 ’19: $2MQ4 ’19Q1 ’20: $3MQ2 ’20: $3MQ2 ’20Q3 ’20: $3MQ4 ’20: $4MQ4 ’20Q1 ’21: $4MQ2 ’21: $4MQ2 ’21Q3 ’21: $4MQ4 ’21: $4MQ4 ’21Q1 ’22: $4MQ2 ’22: $4MQ2 ’22Q3 ’22: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 202252.8K$4M+1.02%
Q2 202253.1K$4M+1.07%
Q1 202252.6K$4M+0.93%
Q4 202166.1K$4M+0.98%
Q3 202172.9K$4M+1.09%
Q2 202166.3K$4M+1.16%
Q1 202169.2K$4M+1.32%
Q4 202061.5K$4M+1.27%
Q3 202057.6K$3M+1.36%
Q2 202053.4K$3M+1.39%
Q1 202048.3K$3M+1.47%
Q4 201932.3K$2M+0.89%
Q3 201919.3K$980,000+0.48%
Q2 201914.6K$663,000+0.34%
Q1 20196.6K$315,000+0.19%
Q4 20185.2K$272,000+0.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Surevest, LLC’s full portfolio or all institutional holders of BMY.